Johnson & Johnson, South Africa
To raise awareness and contribute to addressing policy issues impacting availability and access to medicines in Sub-Saharan Africa. To contribute to the body of knowledge on the nature and impact of technical barriers to the availability of medicines in Africa.
Education and experience:
Kirti Narsai is a professional PhD candidate with the Utrecht WHO Collaborating Centre. She has been working in the healthcare industry since 1997, based in South Africa. Currently, she is employed at Johnson & Johnson as Senior Director, Government Affairs & Policy for Sub-Saharan Africa. Previously, she has also worked at the trade association for Pharmaceuticals in South Africa.
Kirti holds a Bachelor’s degree in Pharmacy and a Masters degree in Pharmaceutics from the North West University in South Africa. She also holds an MBA from the Gordon Institute of Business Science, University of Pretoria, South Africa.
Title PhD project:
Regulatory diversity in Sub-Saharan Africa
PhD project description:
There is very little data on the technical barriers experienced by companies in making products available through the market authorization process in African countries. Current data and publications are limited to the resource and technical capacity challenges in National Medicines Regulatory Authorities (NMRAs). These factors have a direct impact on the availability of medicines on markets in SSA. The research therefore aims to unpack the nature and extent of the challenges experienced in obtaining market authorization.
The results of the research will contribute to the limited body of knowledge in this area and also influence the policymaking process as the regulatory harmonization processes for medicines progress in SSA.
Team members and other people involved:
Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa: Kirti Narsai · Abeda Williams · Aukje Kaija Mantel-Teeuwisse